GlassScriptPhysician profile
Philip A Rascoe
NPI 1568660157
$11,374.05
in general payments reported to CMS, 2019-2025
18 companies · $593 in 2025
The $593 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $866 · 2020: $186 · 2021: $318 · 2022: $8,418 · 2023: $377 · 2024: $617 · 2025: $593.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,587.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,586.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $9,587.41 | 2019-2024 | |
| Atricure, INC. | $444.69 | 2023-2025 | Atricure Cryoice Cryosphere Cryoablation System, Synergy Ablation System, Atriclip Laa Exclusion System |
| Medtronic, INC. | $407.12 | 2021-2025 | Bio-Flek, Endurant Iis |
| W. L. Gore & Associates, INC. | $207.41 | 2022-2023 | Gore Tag Thoracic Branch Endoprosthesis |
| Edwards Lifesciences Corporation | $163.60 | 2025 | Konect Resilia |
| Abiomed | $149.14 | 2021 | |
| Davol INC. | $104.55 | 2019-2020 | |
| Shockwave Medical, INC | $49.29 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Cagent Vascular INC | $41.16 | 2025 | Serrantor |
| Solventum Corporation | $39.19 | 2024 | V.A.C. Veraflo Cleanse Choice, Prevena |
| Polynovo North America LLC | $37.18 | 2024 | Novosorb Btm |
| Stryker Corporation | $30.15 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Bard Peripheral Vascular, INC. | $23.64 | 2021 | |
| Acera Surgical, INC. | $21.36 | 2025 | Restrata Wound Matrix |
| Mozarc Medical US LLC | $20.55 | 2024 | Palindrome |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acell, INC. | $20.15 | 2019 | |
| Baxter Healthcare | $13.95 | 2019 | |
| Smith+Nephew, INC. | $13.51 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Philip Rascoe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.